Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.01849 | 76 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.4017 | 78 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.44679 | 78 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.7039 | 79 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.95878 | 75 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.20011 | 78 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.6411 | 73 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.37152 | 78 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.35864 | 78 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.12138 | 76 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.21619 | 77 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.18241 | 76 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.95435 | 75 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.19021 | 77 |